Novel therapies for diabetes mellitus
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2012, Vol 29, Issue 2
Abstract
This review paper summarizes currently available data on the development of newer categories of antidiabetic agents, their ways of action and their clinical importance. During recent years significant achievements have been made in this field, including the development of SGLT2 inhibitors and glucokinase activators. The role of the metabolism of free fatty acids and bile acid in the treatment of diabetes mellitus is also reviewed.
Authors and Affiliations
A. PAPAZAFIROPOULOU, M. KARDARA, S. Pappas
Keywords
Related Articles
- EP ID EP161082
- DOI -
- Views 79
- Downloads 0
Churg-Strauss syndrome
No abstract available
Day surgery - Perspectives: Views and attitudes of Greek NHS physicians
OBJECTIVE This study explores the views of doctors regarding the advantages and benefits of one day surgical clinic procedures and their intention to support the application in clinical practice. METHOD One hundred an...
Recent advances in the treatment of sepsis syndrome
Τhe modern concept of the effective management of the septic patient involves support with fluids, artificial respiration and inotropic agents and removal of the septic focus. This latter goal may be achieved by either s...
Enhancement by arachidonic acid of the activity of antibiotics<br /> on experimental by multidrug-resistant Pseudomonas aeruginosa sepsis
OBJECTIVE Treatment of experimental multidrug-resistant Pseudomonas aeruginosa sepsis with intravenous co-administration of arachidonic acid (AA), ceftazidime and amikacin. METHOD The study was conducted using 21 rabb...
Η υπολευκωματιναιμία στους χρόνια αιμοκαθαιρόμενους ασθενείς<br /> Συχνότητα, βαρύτητα και αιτιολογικοί παράγοντες
ΣΚΟΠΟΣ Η υπολευκωματιναιμία αποτελεί συχνή διαταραχή στους χρόνια αιμοκαθαιρόμενους ασθενείς. Τα κυριότερα αίτιά της είναι η συστηματική φλεγμονώδης αντίδραση και η κακή διατροφή, ενώ και η ανεπαρκής αιμοκάθαρση φαίνεται...